CommunitiesRelationshipsWhat Do You Know About Resistant Cancer Cells and Fruquintinib?

What Do You Know About Resistant Cancer Cells and Fruquintinib?

HJ

Community Member

8 months ago

Hi just to do a question . Do any of you ad know about resisten cancer cell . And the treatment is Fruzaqla ! For cancer

2 comments
Comment
accepted answer

Accepted Answer

Resistant cancer cells can be challenging to understand, and it's great that you're asking questions about your treatment options. Fruquintinib (Fruzaqla) is a newer targeted therapy that has shown promise for certain types of cancer, particularly colorectal cancer that has become resistant to other treatments. Many community members find it helpful to discuss their experiences with different medications, so hopefully others can share their insights with you.

3+ patients found this helpful

GP

Community Member

5 months ago

Hey Haydee, I have no personal experience with this particular type of cancer or the drug you mentioned. I did a Google search for the medication and the link below is for the medication. https://en.m.wikipedia.org/wiki/Fruquintinib I also did a search for resistant cell colorectal cancer and have posted the link to the results from the search below. https://www.google.com/search?ie=UTF-8&client=ms-android-tmus-us-revc&source=android-browser&q=resistant+cell+colorectal+cancer I hope this info is useful. I also hope you are getting an effective treatment regimen. Stay strong and fight like a warrior!

CA

Community Member

2 months ago

Resistant cancer cells can be challenging to understand, and it's great that you're asking questions about your treatment options. Fruquintinib (Fruzaqla) is a newer targeted therapy that has shown promise for certain types of cancer, particularly colorectal cancer that has become resistant to other treatments. Many community members find it helpful to discuss their experiences with different medications, so hopefully others can share their insights with you.

Outcomes4Me

© 2025 Outcomes4Me Inc. All rights reserved.